Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | SVP, People and Health Service | March 01, 2023 | March 10, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date March 01, 2023 · Filed March 10, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.32 · Expires 2033-03-01 | Direct | 11,690 |
Reported balance
After 2023-03-01 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-03-01 · Grant · Acquired 11,690 · Balance 11,690 F1: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F2: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person. F3: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
F2: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.
F3: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC | Chemours Co CC · Entity 4420 | GrantPerformance Stock Option (Right to Buy) · Derivative | 11,232 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · derivative · entry 4 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,232 Underlying: Common Stock · 11,232 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 11,393 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · derivative · entry 3 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,393 Underlying: Common Stock · 11,393 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 5,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,275.8412 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 921 | $34.84 | $32,087.64 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,253.8412 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 10, 2023 13:38 UTC Amendment | Chemours Co CC · Entity 4420 | GrantPerformance Option (Right to Buy) · Derivative | 11,690 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-017755 · doc4a.xml · derivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,690 Underlying: Common Stock · 11,690 shares Expires 2033-03-01 F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person. F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 13:11 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 28,315 | $34.35 | $972,620.25 |
DisclosureSEC source: 0001209191-23-009038 · doc4.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,174.8412 F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 13:11 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 68,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009038 · doc4.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,489.8412 F1 · shares: Vesting of performance share units (PSUs) F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:12 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 28,311 | $0.00 Strike: $25.98 | $0.00 |
DisclosureSEC source: 0001627223-22-000013 · primary_doc.xml · derivative · entry 3 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,311 Underlying: Common Stock · 28,311 shares Expires 2032-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2023. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:12 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-22-000013 · primary_doc.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,849.1085 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2023. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:12 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 320 | $25.98 | $8,313.60 |
DisclosureSEC source: 0001627223-22-000013 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,155.1085 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 17:47 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 1,928 | $30.00 | $57,840.00 |
DisclosureSEC source: 0001627223-22-000006 · primary_doc.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,475.8383 F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 17:47 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 5,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-22-000006 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,403.8383 F1 · shares: Vesting of performance share units (PSUs) F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 13:29 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 28,629 | $0.00 Strike: $24.01 | $0.00 |
DisclosureSEC source: 0001627223-21-000017 · primary_doc.xml · derivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,629 Underlying: Common Stock · 28,629 shares Expires 2031-03-01 F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 13:29 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000017 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,586.3012 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 15:57 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 449 | $26.14 | $11,736.86 |
DisclosureSEC source: 0001627223-21-000004 · primary_doc.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,371.301 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F3 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 15:57 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 1,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000004 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,820.301 F1 · shares: Vesting of performance share units (PSUs) F3 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 12:31 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 19,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000044 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,625.301 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on December 1, 2023. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:44 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 289 | $13.57 | $3,921.73 |
DisclosureSEC source: 0001627223-20-000036 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,872 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:08 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 74,866 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000020 · primary_doc.xml · derivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,866 Underlying: Common Stock · 74,866 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:32 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 2,626 | $19.37 | $50,865.62 |
DisclosureSEC source: 0001627223-20-000010 · primary_doc.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,182 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:32 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 7,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000010 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,808 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| May 17, 2019 Filed May 20, 2019 21:59 UTC | Chemours Co CC · Entity 4420 | PurchaseCommon Stock | 6,500 | $23.06 | $149,878.30 |
DisclosureSEC source: 0001627223-19-000032 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,693 F1 · price: Price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $23.04 to $23.10. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 20:48 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 16,724 | $0.00 Strike: $38.02 | $0.00 |
DisclosureSEC source: 0001627223-19-000013 · primary_doc.xml · derivative · entry 1 Kelliher Susan M. · CIK 0001568507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,724 Underlying: Common Stock · 16,724 shares Expires 2029-03-01 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on March 1, 2020. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:50 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 271 | $49.31 | $13,363.01 |
DisclosureSEC source: 0001627223-18-000034 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 F1 · shares: Shares withheld for tax obligations on vested restricted stock units (RSUs) and dividend equivalent units (DEUs). No shares were sold. F2 · balance_after: Includes directly owned shares, unvested RSUs and DEUs. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:36 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 9,732 | $0.00 Strike: $48.53 | $0.00 |
DisclosureSEC source: 0001627223-18-000012 · primary_doc.xml · derivative · entry 1 Kelliher Susan M. · CIK 0001568507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,732 Underlying: Common Stock · 9,732 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 1, 2019. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 16:36 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 8,864 | $0.00 Strike: $41.51 | $0.00 |
DisclosureSEC source: 0001627223-17-000044 · primary_doc.xml · derivative · entry 2 Kelliher Susan M. · CIK 0001568507 · Senior VP of Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,864 Underlying: Common Stock · 8,864 shares Expires 2027-06-01 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 16:36 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-17-000044 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · Senior VP of Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 F1 · shares: Restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.